首页> 美国卫生研究院文献>Clinical and Developmental Immunology >Erratum to Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients

【2h】

Erratum to Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients

机译：勘误表低基线白细胞介素17A水平与类风湿关节炎患者在第12周接受Tocilizumab治疗的治疗反应更好相关

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Clinical and Developmental Immunology
作者
Sang Jin Lee; Won Park; Sung Hwan Park; Seung-Cheol Shim; Han Joo Baek; Dae-Hyun Yoo; Hyun Ah Kim; Soo Kon Lee; Yun Jong Lee; Young Eun Park; Hoon-Suk Cha; Jin Kyun Park; Eun Young Lee; Eun Bong Lee; Yeong Wook Song;
展开▼
作者单位

展开▼
年(卷),期 2017(2017),-1
年度 2017
页码 7869412
总页数 1
原文格式 PDF
正文语种
中图分类免疫学;
关键词

相似文献

外文文献
中文文献
专利

1. Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients [J] . Sang Jin Lee, Won Park, Sung Hwan Park, Clinical & developmental immunology. . 2015,第1期

机译：低基线白细胞介素17A水平与类风湿关节炎患者在第十二周接受Tocilizumab治疗的治疗反应更好相关
2. Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients [J] . Sang Jin Lee, Won Park, Sung Hwan Park, Clinical & developmental immunology. . 2015,第1期

机译：低基线白细胞介素-17a水平与12周内的更好的治疗反应相关，以在类风湿性关节炎患者中进行透明珠酮治疗
3. A randomized, double-blind, parallel-group, phase III study of shortening the dosing interval of subcutaneous tocilizumab monotherapy in patients with rheumatoid arthritis and an inadequate response to subcutaneous tocilizumab every other week: Results of the 12-week double-blind period [J] . Ogata Atsushi, Tanaka Yoshiya, Ishii Tomonori, Modern rheumatology . 2018,第1期

机译：随机，双盲，并行组，第三阶段研究缩短皮下对毒素关节炎患者的皮下对照单药治疗和对皮下对照的反应不充分的每隔一周：12周双盲时期的结果
4. Hyaluronic Acid-Gold Nanoparticle-Tocilizumab Complex for the Treatment of Rheumatoid Arthritis [C] . Hwiwon Lee, Min-Young Lee, Ki Su Kim, Society for biomaterials annual meeting and exposition . 2013

机译：透明质酸-金纳米颗粒-托珠单抗复合物治疗类风湿关节炎
5. Patient Treatment Priorities and Patient-Centered Care in Rheumatoid Arthritis [D] . Dibie, Chukwuebuka. 2020

机译：患者治疗优先事项和患者以类风湿性关节炎为中心护理
6. Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients [O] . Sang Jin Lee, Won Park, Sung Hwan Park, 2015

机译：低基线白细胞介素17A水平与类风湿关节炎患者在第12周接受Tocilizumab治疗的治疗反应更好相关
7. A randomized, double-blind, parallel-group, phase III study of shortening the dosing interval of subcutaneous tocilizumab monotherapy in patients with rheumatoid arthritis and an inadequate response to subcutaneous tocilizumab every other week: Results of the 12-week double-blind period [O] . Atsushi Ogata, Yoshiya Tanaka, Tomonori Ishii, 2017

机译：随机，双盲，并行组，第三阶段研究缩短了类风湿性关节炎患者的皮下对硅酸化单药治疗的剂量间隔及对皮下丁证的反应不足：12周双盲期的结果

Erratum to Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients

著录项

相似文献

相关主题

期刊订阅